In NASH, AKR1B10 upregulation may lead to mitochondrial dysfunction, disrupt redox reaction balance, and cause excessive reactive oxygen species production, thereby inducing oxidative hepatocyte damage [52]. This evidence concerns the gene AKR1B10 and metabolic dysfunction-associated steatohepatitis.